Picture of Biotest AG logo

BIO3 Biotest AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeMid CapMomentum Trap

Momentum

Relative Strength (%)
1m-5.76%
3m-8.48%
6m-6.9%
1yr-5.87%
Volume Change (%)
10d/3m+99.99%
Price vs... (%)
52w High-13.2%
50d MA-0.69%
200d MA-2.23%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)615.53
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)0.12%
Valuation (ttm)IndustryMarket
Price to Book Value3.94
Price to Tang. Book4.08
Price to Free Cashflown/a
Price to Sales2.68
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-5.67%
Return on Equity-18.75%
Operating Margin-10.89%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biotest AG EPS forecast chart

Profile Summary

Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
July 31st, 2006
Public Since
December 15th, 2016
No. of Employees
2,074
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
39,571,452
Blurred out image of a map
Address
Landsteinerstr. 5, DREIEICH, 63303
Web
https://www.biotest.com/
Phone
+49 61038010
Auditors
KPMG AG Wirtschaftsprufungsgesellschaft

BIO3 Share Price Performance

Upcoming Events for BIO3

FAQ

Or unlock with your email

Or unlock with your email